Skip to main content Skip to footer

Lung Transplant Program

Expert care for advanced lung disease


Baylor Annette C. and Harold C. Simmons Transplant Institute at Baylor University Medical Center, part of Baylor Scott & White Health is one of the largest, most comprehensive multi-specialty transplant centers in the United States. Our lung transplant program offers sophisticated diagnostic testing and innovative therapies for patients with advanced chronic lung disease.

Since performing our first lung transplant in Texas in 1990, our team continues to be a leading force in lung disease treatment and outcomes. Baylor Dallas is not only home to one of the busiest adult extra corporeal membrane oxygenation (ECMO) programs in North Texas, but also home to the region's only ECMO deployment program. Transplant outcomes at Baylor Dallas are excellent and one year survival rates continue to improve despite increased severity of illness in patients. Waitlist times continue to decrease as transplant volumes steadily increase.

Baylor Dallas is the top-ranked hospital in North Texas in pulmonology and continues to be ranked as one of America's top hospitals by U.S. News & World Report. We accept chronic lung disease patients with complex conditions that other centers may deny. In addition, we are actively involved in research to improve outcomes after lung transplantation. ​

Our experienced lung transplant team includes:

  • Coordinators
  • Nurses
  • Social workers
  • Nutritionists
  • Physical therapists
  • Respiratory therapists
  • Transplant pulmonologist
  • Surgeons
  • Anesthesiologists on the medical staff

For more information on the Baylor Dallas Lung Transplant Program, call 214.820.6856 or explore the information below.

Our team of lung transplant specialists


We performed our first lung transplant in Texas in 1990 and have continued to grow our lung disease treatment expertise and experience. Our team includes:

Lung transplant surgery:

  • David Mason, MD, chief lung transplantation and thoracic surgery
  • Gary Schwartz, MD, surgical director of major airway disorders
  • Leonidas Tapias, MD, surgeon, thoracic surgery and lung transplantation
  • Eitan Podgaetz, MD, surgeon, thoracic surgery and lung transplantation

Lung transplant pulmonology:

  • Todd Grazia, MD, chief of transplant pulmonology
  • Randall L. Rosenblatt, MD, chief of pulmonary medicine
  • Puneet Garcha, MD, assistant medical director of lung transplantation and advanced lung disease
  • Chetan Naik, MD, transplant pulmonologist

Advanced lung disease:

  • Kenneth Ausloos, MD, associate director for the Center for Advanced Lung Disease
  • Yolanda Mageto, MD, medical director, interstitial lung disease
  • Susan Mathai, MD, interstitial lung disease, critical care medicine
  • Haala Rokadia, MD, interstitial lung disease, critical care medicine
  • Mohammad Mogri, MD, interstitial lung disease, critical care medicine​

Patient education

If you may be a candidate for transplantation, Baylor Scott & White Health is here to help you every step of the way.

  • Twice Blessed House – Dallas
  • Resources

Twice Blessed House – Dallas

Twice Blessed House is dedicated to serving pre- and post-transplant patients and their caregivers by providing a warm family atmosphere and amenities needed for daily living.


There are a variety of support and educational resources offered through Baylor and outside organizations, which can help patients and their families better understand and cope with lung disease and the transplantation process.

Diagnosis for lung transplant

There are a number of serious lung conditions, in which single or double lung transplant may be the best course of treatment

  • Emphysema
  • Chronic obstructive pulmonary disease (COPD)
  • Pulmonary fibrosis/Interstitial Lung Disease
  • Cystic fibrosis
  • Pulmonary hypertension
  • Bronchiolitis
  • Bronchiectasis
  • Lymphangioleiomyomatosis
  • Sarcoidosis
  • Occupational lung disease
  • Congenital heart disease with pulmonary hypertension (heart-lung transplant)

Center for Advanced Heart & Lung Disease

The Center for Advanced Heart & Lung Disease provides diagnosis and comprehensive treatment of individuals with chronic lung disease, connective tissue disease, cystic fibrosis, interstitial lung disease and pulmonary fibrosis. We perform advanced diagnostic procedures and highly specialized evaluations for the proper identification and treatment of complex lung disorders. The treatment team including physicians who specialize in advanced lung disease consults together with other medical, surgical and pulmonary rehabilitation specialists to devise a treatment plan that gives hope for our patients to receive the best possible outcome and improved quality of life. 

Among the advanced treatments and clinical research provided are:

  • Clinical trials in the treatment of usual interstitial pneumonia (pulmonary fibrosis)
  • Minimally invasive lung volume reduction surgery (LVRS) for emphysema
  • Extracorporeal membrane oxygenation (ECMO) for severe respiratory failure and adult respiratory distress syndrome (ARDS)

Ask the Experts

Watch a video of David P. Mason, MD, thoracic and lung transplant surgeon at Baylor Scott & White Health, discussing surgical options for lung transplantation.


Frequently asked questions


The duration a patient may wait for a lung transplant is primarily determined by illness severity—which is calculated as the Lung Allocation Score (LAS). Sicker patients with higher LAS scores are ranked higher on the wait list. Other factors that influence donor compatibility include rare blood types, preformed antibodies and lung size, and may also affect wait times.

Once listed for lung transplantation, you will be followed closely in the transplant clinic and your score will be updated routinely to determine your sequence on the wait list.

We have a financial coordinator who will help you and your family with financial related questions or concerns regarding your transplant coverage.

Yes. A single or double lung transplant may be the best course for cystic fibrosis treatment.

Yes. Chronic obstructive pulmonary disease (COPD) can be treated with lung transplantation.

The use of a single versus double lung transplant involves several factors. Recipient age, type of lung disease, presence of pulmonary hypertension and severity of a patient's illness are the main factors. Donor availability also influences the decision to perform a single lung transplant—as many circumstances of organ donors make only one lung acceptable for transplantation.

In general, older patients do equally well with single lung transplantation as compared to double lung transplantation. In most circumstances for patients younger than 55 years old, a double lung transplant is preferred.

The cost of lung transplantation is ultimately a life-long expense, in a large part due to the daily cost of anti-rejection medications and routine surveillance of the organ's function and well-being. It is essential for patients with chronic lung disease to maintain health insurance.

Once referred by your doctor to Baylor, a carefully coordinated set of tests will be scheduled to determine your candidacy. Testing generally begins within seven days of referral and the total testing time typically takes two and a half full days. These tests are performed at Baylor University Medical Center, part of Baylor Scott & White Health. You will be counseled extensively about the process of transplantation and what to expect from lung function and quality of life after transplant. The Baylor team members with whom you will meet include transplant pulmonologists, surgeons and cardiologists on the medical staff, along with nutritionists, social workers, financial counselors and physical therapists, among others.

Our transplant team evaluates patients on a case-by-case basis and focuses on a patient's physiologic age (functional age) an​d overall health for determination of candidacy. Advanced age (over 65 years old) is a risk for shorter survival after lung transplantation—primarily as a consequence of other illnesses. Ordinarily, patients older than 65 are considered for lung transplantation if, with the exception of lung disease, they are otherwise healthy.

After your doctor refers you to Baylor Dallas for lung disease treatment, you'll undergo a series of tests and counseling to determine if you are a candidate for a lung transplant. The Lung Transplant Selection Committee will review the results to evaluate if you meet the lung transplant requirements. If so, you will be approved and placed on the list for transplant. Once on the waiting list, you'll be assigned a standard Lung Allocation Score (LAS). Lungs are allocated to recipients according to the lung allocation score, blood type and geographic matching between donor and recipient.

Once listed, you must be in contact and available within a three-hour radius of Baylor Dallas for a donor offer. Our transplant coordinator will contact you and provide all instructions. If you live at a farther distance, our transplant coordinator may arrange private air transportation. During your pre-transplant clinic visits, your transplant coordinator will make sure that you and your family know what to expect immediately before and after surgery. During transplantation, your coordinator will deliver regular updates to your family. For more detailed information, please consult the patient handbook.

Patients who have undergone lung transplantation report a dramatic improvement in their quality of life. Following recovery from lung surgery, patients no longer require supplemental oxygen and are able to return to an active lifestyle with considerably more independence with their daily lives. On average, full recovery and physical rehabilitation following lung transplantation surgery takes 2-3 months.

Immediately after transplant, you will be brought to the intensive care unit where you typically stay for two days. You will have many tubes and drains after surgery that will be removed over the first few days after transplant. Your pain will be controlled with intravenous and oral pain medications. Physical therapy will begin immediately after surgery in the intensive care unit. Prior to discharge, you will be given a list of your medications and their importance and instructed how to appropriately take them. On average, you will be in the hospital for two weeks after transplant.

Once leaving the hospital, your lung transplant team will manage all aspects of your medical care for at least the first year after surgery. At these visits, blood tests, radiologic imaging and bronchoscopic (telescope into the windpipe) biopsies are performed routinely. These biopsies are performed on an outpatient basis to evaluate for rejection, a potential response of your body against the transplanted lung. Blood tests are performed to monitor the levels of your anti-rejection medications. After one year, we coordinate your medical care with your primary care physician or pulmonologist. Routine visits to Baylor Dallas will continue to be necessary throughout the remainder of your life. Visits become more spread out as time from transplant progresses.

  • Register to become an organ donor

    By becoming an organ donor, you could save a life. Or more. With more than 120,000 people on organ transplant waiting lists in the United States, organ donation needs are critical.

Scroll To Top